Rituximab induces a rapid and sustained remission in Colombian patients with severe and refractory systemic lupus erythematosus. [electronic resource]
Producer: 20120203Description: 1219-26 p. digitalISSN:- 1477-0962
- Adult
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Cohort Studies
- Colombia
- Creatinine -- blood
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Immunosuppressive Agents -- therapeutic use
- Lupus Erythematosus, Systemic -- drug therapy
- Lupus Nephritis -- therapy
- Male
- Prospective Studies
- Proteinuria -- therapy
- Remission Induction
- Rituximab
- Treatment Failure
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.